Novo Holdings A/S
CIK 0001388325 · HELLERUP, null · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source ↗
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$1.72B
2026 Q2
Positions
25
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
73.5%
Est. Net Flow (Q)
—
2026 Q2
Top Holdings
EWTX
EDGEWISE THERAPEUTICS INC
12.6%
ASML
ASML HOLDING N V
11.0%
COAG
HEMAB THERAPEUTICS HLDGS INC
8.9%
BN
BROOKFIELD CORP
8.7%
MPLT
MAPLIGHT THERAPEUTICS INC
7.7%
MIRM
MIRUM PHARMACEUTICALS INC
7.6%
AVLN
AVALYN PHARMACEUTICALS INC
7.4%
CRM
SALESFORCE INC
3.6%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.